| anencephaly | ||||
| Disease ID | 219 |
|---|---|
| Disease | anencephaly |
| Integrated Phenotype | HPO | Name(Total Integrated Phenotypes:2) |
| Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:7) |
| Disease ID | 219 |
|---|---|
| Disease | anencephaly |
| Manually Symptom | (Waiting for update.) |
| Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
All Snps(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
Mapped by lexical matching(Total Items:1) | ||||
|---|---|---|---|---|
| HP ID | HP Name | MP ID | MP Name | Annotation |
| HP:0008207 | Primary adrenal insufficiency | MP:0008295 | abnormal adrenal gland zona reticularis morphology;HP:0002414 | Spina bifida |
Mapped by homologous gene(Total Items:1) | ||||
|---|---|---|---|---|
| HP ID | HP Name | MP ID | MP Name | Annotation |
| HP:0002323 | Anencephaly | MP:0010465 | aberrant origin of the right subclavian artery;HP:0008207 | Primary adrenal insufficiency |
Chemical(Total Drugs:4) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
| C0002902 | azacitidine | D001374 | 320-67-2 | anencephaly | MESH:D000757 | marker/mechanism | 11875660 | ||
| C0002902 | folic acid | D005492 | 59-30-3 | anencephaly | MESH:D000757 | therapeutic | 12397633 | ||
| C0002902 | methadone | D008691 | 76-99-3 | anencephaly | MESH:D000757 | marker/mechanism | 4586767 | ||
| C0002902 | thalidomide | D013792 | 50-35-1 | anencephaly | MESH:D000757 | marker/mechanism | 21505091 | ||
FDA approved drug and dosage information(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA labeling changes(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |